Go to Top


PhD Fellowship at Iproteos, Barcelona

JOB TITLE:                   Early Stage Researcher (ESR)                                                              

Company:                   Iproteos

Supervised by:      Dr. Teresa Tarragó

Area of study:         This position is funded by a Marie Curie Initial Training Network Initiative. The network,

Read More

Angewandte Paper – Roger Prades and Ernest Giralt

Roger Prades, Iproteos CSO, is the first author of an article published this January at Angewandte Chemie reporting a novel peptide capable of overcoming the blood-brain barrier. The work has been possible through the collaboration of a team composed by scientists at IRB Barcelona, RCSI, ISD, INA and UB.

The BBB-shuttle is a retro-enantio peptide that is protease-resistant, non-toxic and has the ability of transporting cargos of distinct sizes and types across this

Read More

“Barcelona city” 2014 prize awarded to Ernest Giralt

Ernest Giralt, co-founder of Iproteos, has been awarded with the “Barcelona City” 2014 prize in the category of Experimental Sciences and Technology. The jury has recognized Prof. Giralt for his development of a technology that allows a cytotoxic peptide from the bee poison to target only tumor cells, without affecting the healthy ones, being therefore, a therapeutic approach with application in chemotherapy.

The award ceremony has taken place today,

Read More


Barcelona BioMed Conference on Blood Brain Barrier

Roger Prades, Iproteos CSO will participate at the Barcelona BioMed Conference “Blood Brain Barrier” that will be held next November 2-4. Roger will give a short talk that will be entitled “IPR19: a prolyl oligopeptidase inhibitor for the treatment of cognitive impairment associated with schizophrenia”. The talk will be delivered on Thursday 3 in the afternoon, at the “Institut d’Estudis Catalans”.

This Barcelona BioMed Conference is organized by Prof.

Read More

Innovation Days – October 2015

Teresa Tarragó will participate at the Innovation Days 2015, a partnering meeting in Open Innovation for Life Sciences. It will take place from 5-6 of October and it is held in Paris. The event features conferences and workshops together with one-to-one partnering meetings.

Iproteos CEO will be on Tuesday 6th of October seeking for partnerships and business opportunities. You can know more about our pipeline, and the potential of

Read More

Teresa Tarragó at the 2nd CRG BioBusiness School – October 2015

On 5th of October 2015, Teresa Tarragó, Iproteos CEO, will give the Keynote Lecture at the 2nd CRG BioBusiness School. The 5-day course is aimed to go deep into the Tech Transfer at Science a key aspect in the world of biotech. Participants will learn how to identify projects with potential to be transferred to a company or to create a spin-off. Besides, students will generate their very own

Read More